Gretchen Kimmick is an Oncology physician affiliated with Duke University. OpenAlex indexes 267 publications with 7,839 citations (h-index 47); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2100 Erwin Rd Dumc Box 3204
Durham, NC 277100001
Telephone
919-620-4467Registry record last updated 9 Sept 2013.
Clinical trials
- Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery
Sponsor: Wake Forest University Health Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20251 payment
- Merck Sharp & Dohme LLCProgram year20241 payment
- NOVARTIS PHARMACEUTICALS CORPORATIONProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
87.5%Aromatase Inhibitor55.4%Anastrozole64%Letrozole36%Part D≥64 patientsKinase inhibitor23%Verzenio53%Ibrance35%Kisqali12%Part D<11 patients+ 2 more classes in this area
Nervous system
8.6%SNRI3.1%Venlafaxine Hcl Er100%Part D<11 patientsOther antidepressants2.9%Mirtazapine100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.8%Potassium supplement3.8%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2026–2026 per NIH RePORTER. The latest:
- Geriatric oncology assessment to link with support for older women taking adjuvant aromatase inhibitor therapy
Duke University
FY2026$668,691R01CA309588
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Older adult participation in cancer clinical trials: A systematic review of barriers and interventions
CA A Cancer Journal for Clinicians
2020 - Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials
Journal of Geriatric Oncology
2019 - Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer
Journal of the American Geriatrics Society
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Pamela Douglas, MD
Duke University
Adrian Hernandez, MD
Duke University
Jonathan Piccini, MD
Duke University
Vance Fowler, MD
Duke University
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”